Esterified Estrogens And Methyltestosterone Tablet
Product Images NDC 63629-9177

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Esterified Estrogens And Methyltestosterone (NDC 63629-9177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ab03b87f-figure-01 (Esterified Estrogens And Methyltestosterone Tablet 1)

FDA Label Image

Ab03b87f-figure-02 (Esterified Estrogens And Methyltestosterone Tablet 2)

The text describes a table that shows the relative and absolute risk seen in the CE/MPA Substudy of WHI. The table includes different events with their respective data like the absolute risk per 10,000 women-years, relative risk, and confidence intervals. Some of the events in the table include CHD events, nonfatal MI, invasive breast cancer, stroke, pulmonary embolism, colorectal cancer, endometrial cancer, hip fracture, death due to causes other than the events mentioned above, global index, deep vein thrombosis, vertebral fractures, and other osteoporotic fractures.*

FDA Label Image

Label (Lbl636299177)

This is a pharmaceutical label for Esterified Estrogens and Methyltestosterone Tablets, each containing 1.25 mg and 2.5 mg respectively. The package contains 100 tablets with instructions to store between 20-25°C and a caution to keep out of reach of children. It contains a dispenser and a patient information leaflet with dosages which can be considered after reading the package insert for full prescribing information. The NDC number is 63629-9177-1.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.